Back to company

SCANPHARM A/S: Financial statements 2016

CVR: 16279099

SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 19,626,649 and a net result of DKK 1,267,088 compared with DKK 715,522 the year before. That is a decrease of 4% compared with the year before. Equity amounted to DKK 12,971,605. The solvency ratio was 38.8%. The company had 42 employees in the financial year.

Gross Profit
19,626,649 kr.
Profit/Loss
1,267,088 kr.
Equity
12,971,605 kr.
Total Assets
33,401,535 kr.
Employees
42

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-19.6 mio.1.3 mio.13 mio.42
2015-20.4 mio.716 t.11.7 mio.42
2014-20.8 mio.431 t.11 mio.-
2013-20.9 mio.400 t.10.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is SCANPHARM A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

SCANPHARM A/S: The 2015 annual report is outMay 30, 2016

SCANPHARM A/S has published its annual report for 2015. Gross profit came to DKK 20,446,816, and the net result was DKK 715,522.

About SCANPHARM A/S

SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees. In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity amounted to DKK 3,045,406.